Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment
Natural killer (NK) cells are innate immune effectors capable of broad cytotoxicity via germline-encoded receptors and can have conferred cytotoxic potential via the addition of chimeric antigen receptors. Combined with their reduced risk of graft-versus-host disease (GvHD) and cytokine release synd...
Main Authors: | Ishwar Navin, Michael T. Lam, Robin Parihar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/12/3871 |
Similar Items
-
Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
by: Paris Kosti, et al.
Published: (2018-05-01) -
Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
by: Gaurav Nayyar, et al.
Published: (2019-02-01) -
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
by: Chittepu, V.C.S.R, et al.
Published: (2022) -
CAR-NK Cells in the Treatment of Solid Tumors
by: Ewa Wrona, et al.
Published: (2021-05-01) -
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
by: Alba Rodriguez-Garcia, et al.
Published: (2020-06-01)